{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:36:43Z","timestamp":1777653403390,"version":"3.51.4"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.2169\/internalmedicine.2385-23","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T22:28:47Z","timestamp":1692743327000},"page":"1191-1196","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Arterial Thrombotic and Bleeding Events in Patients Who Develop Cancer after ST-elevation Myocardial Infarction"],"prefix":"10.2169","volume":"63","author":[{"given":"Toshiharu","family":"Fujii","sequence":"first","affiliation":[{"name":"Division of Cardiology, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Puymirat E, Simon T, Cayla G, et al; the USIK, USIC 2000, and FAST-MI investigators. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation 136: 1908-1919, 2017.","DOI":"10.1161\/CIRCULATIONAHA.117.030798"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chatterjee P, Joynt Maddox KE. US national trends in mortality from acute myocardial infarction and heart failure: policy success or failure? JAMA Cardiol 3: 336-340, 2018.","DOI":"10.1001\/jamacardio.2018.0218"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Spoon DB, Psaltis PJ, Singh M, et al. Trends in cause of death after percutaneous coronary intervention. Circulation 129: 1286-1294, 2014.","DOI":"10.1161\/CIRCULATIONAHA.113.006518"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pedersen F, Butrymovich V, Kelbaek H, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol 64: 2101-2108, 2014.","DOI":"10.1016\/j.jacc.2014.08.037"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70: 926-938, 2017.","DOI":"10.1016\/j.jacc.2017.06.047"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Urban P, Mehran R, Colleran R, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur heart J 40: 2632-2653, 2019.","DOI":"10.1093\/eurheartj\/ehz372"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Costa F, van Klaveren D, James S, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389: 1025-1034, 2017.","DOI":"10.1016\/S0140-6736(17)30397-5"},{"key":"8","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"8. Thygesen K, Alpert JS, Jaffe AS, et al.; the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). Circulation 138: e618-e651, 2018.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123: 2736-2747, 2011.","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39: 213-260, 2018.","DOI":"10.1093\/eurheartj\/ehx638"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakamura M, Kimura K, Kimura T, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 84: 831-865, 2020.","DOI":"10.1253\/circj.CJ-19-1109"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Malmborg M, Christiansen CB, Schmiegelow MD, Torp-Pedersen C, Gislason G, Schou M. Incidence of new onset cancer in patients with a myocardial infarction - a nationwide cohort study. BMC Cardiovasc Disord 18: 198, 2018.","DOI":"10.1186\/s12872-018-0932-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Khorana AA. Malignancy, thrombosis and Trousseau: the case for an eponym. J Thromb Haemost 1: 2463-2465, 2003.","DOI":"10.1111\/j.1538-7836.2003.00501.x"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Varki A. Trousseau&apos;s syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723-1729, 2007.","DOI":"10.1182\/blood-2006-10-053736"},{"key":"15","unstructured":"15. Zacharski LR, Schned AR, Sorenson GD. Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res 43: 3963-3968, 1983."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 70: 1194-1201, 1992.","DOI":"10.1002\/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO;2-E"},{"key":"17","unstructured":"17. Callander N, Rapaport SI. Trousseau&apos;s syndrome. West J Med 158: 364-371, 1993."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Krauth D, Holden A, Knapic N, Liepman M, Ansell J. Safety and efficacy of long-term oral anticoagulation in cancer patients. Cancer 59: 983-985, 1987.","DOI":"10.1002\/1097-0142(19870301)59:5<983::AID-CNCR2820590522>3.0.CO;2-O"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146-153, 2003.","DOI":"10.1056\/NEJMoa025313"},{"key":"20","unstructured":"20. Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 33: 654-656, 2015."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mantia C, Uhlmann EJ, Puligandla M, Weber GM, Neuberg D, Zwicker JI. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood 129: 3379-3385, 2017.","DOI":"10.1182\/blood-2017-02-767285"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/9\/63_2385-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T03:29:06Z","timestamp":1714793346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/9\/63_2385-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2385-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"article-number":"2385-23"}}